Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)
Taiwan · Delayed Price · Currency is TWD 24.70
0.00 (0.00%)
At close: Dec 19, 2025
Genomics BioSci & Tech. Market Cap
Genomics BioSci & Tech. has a market cap or net worth of 1.79 billion as of December 19, 2025. Its market cap has increased by 40.74% in one year.
Market Cap
1.79B
Enterprise Value
2.28B
Revenue
563.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.70
Market Cap Chart
Since December 16, 2013, Genomics BioSci & Tech.'s market cap has increased from 1.58B to 1.79B, an increase of 13.18%. That is a compound annual growth rate of 1.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.79B | 28.65% |
| Dec 31, 2024 | 1.39B | -7.69% |
| Dec 29, 2023 | 1.51B | 19.84% |
| Dec 30, 2022 | 1.26B | 11.67% |
| Dec 30, 2021 | 1.13B | 0.78% |
| Dec 31, 2020 | 1.12B | 50.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 234.19B |
| PharmaEssentia | 183.26B |
| Heron Neutron Medical | 82.78B |
| Lotus Pharmaceutical | 74.16B |
| Bora Pharmaceuticals Co., LTD. | 60.97B |
| Lin BioScience | 33.26B |
| Lumosa Therapeutics | 31.33B |
| Center Laboratories | 28.22B |